abstract |
Disclosed are muscarinic agonist compounds comprising oxadiazole derivatives, compositions, and formulations thereof. In addition, a method for synthesizing the oxadiazole compound is disclosed. Further disclosed is a method of treating a subject with the muscarinic agonist or a pharmaceutically acceptable form thereof to enhance cognitive function. [Selection] Figure 1 |